Background: Some patients develop asthmatic symptoms such as wheezing and dyspnea during the course of cough variant asthma (CVA), which are considered precursors of classical asthma. Objectives: To identify the characteristics of such patients, we investigated the nature of CVA patients with or without developing bronchial asthma in the longitudinal study. Methods: In 28 CVA patients whom we could observe over 5 years, duration of coughing, physical examination findings, pulmonary function and bronchial hyperresponsiveness to inhaled methacholine were retrospectively assessed. Results: Of these patients with CVA, 10 developed the asthmatic symptoms of wheezing and dyspnea (precursors of classical asthma) over 5 years. All these 10 patients showed marked bronchial hyperresponsiveness; however, there were no significant differences in the bronchial responsiveness to methacholine between patients with precursors of classical asthma and pure CVA patients who did not wheeze. The duration of coughing had a significant relationship with precursors of classical asthma. Seven patients with precursors of classical asthma developed wheezing in the first year and 1 patient each in the second, third and fourth year. Conclusions: These findings of a 5-year observation suggest that longer duration of coughing may be an important factor that develops precursors of classical asthma in patients with CVA.

1.
Corrao WM, Braman SS, Irwin RS: Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med 1979;300:633–637.
2.
Poe RH, Harder RV, Israel RH, Kallay MC: Chronic persistent cough: Experience in diagnosis and outcome using an anatomic diagnostic protocol. Chest 1989;95:723–728.
3.
Irwin RS, Corrao WM, Pratter MR: Chronic persistent cough in the adult: The spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis 1981;123:413–417.
4.
Irwin RS, Curley FJ, French CL: Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 1990;141:640–647.
5.
Fujimura M, Kamio Y, Hashimoto T, Matsuda T: Cough receptor sensitivity and bronchial responsiveness in patients with only chronic nonproductive cough: In view of effect bronchodilator therapy. J Asthma1994;31:463–472.
6.
Hannaway PJ, Hopper DK: Cough variant asthma in childhood. JAMA 1982;247:206–208.
7.
Konig P: Hidden asthma in childhood. Am J Dis Child 1981;135:1053–1055.
8.
Koh YY, Jeong JH, Park Y, Kim CK: Development of wheezing in patients with cough variant asthma during an increase in airway responsiveness. Eur Respir J 1999;14:302–308.
9.
Kim CK, Kim JT, Kang H, Yoo Y, Koh YY: Sputum eosinophilia in cough-variant asthma as a predictor of the subsequent development of classic asthma. Clin Exp Allergy 2003;33:1409–1414.
10.
Yoo Y, Koh YY, Kang H, Yu J, Nah KM, Kim CK: Sputum eosinophil counts and eosinophil cationic protein levels in cough-variant asthma and in classic asthma, and their relationships to airway hypersensitivity or maximal airway response to methacholine. Allergy 2004;59:1055–1062.
11.
McGarvey LP, Heaney LG, Lawson JT, Johnston BT, Scally CM, Ennis M, Shepherd DR, MacMahon J: Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax 1998;53:738–743.
12.
Takishima T, Hida W, Sasaki H, Suzuki S, Sasaki T: Direct-writing recorder of the dose-response curve of the airway to methacholine. Clinical application. Chest 1981;80:600–606.
13.
Cloutier MM, Loughlin GM: Chronic cough in children: A manifestation of airway hyperreactivity. Pediatrics 1981;67:6–11.
14.
O’Connell EJ, Rojas AR, Sachs MI: Cough-type asthma: A review. Ann Allergy 1991;66:278–285.
15.
Konig P: Cough variant asthma. J Asthma 1991;28:83–84.
16.
Johnson D, Osborn LM: Cough variant asthma: A review of the clinical literature. J Asthma 1991;28:85–90.
17.
Coleridge HM, Coleridge JC, Ginzel KH, Baker DG, Banzett RB, Morrison MA: Stimulation of ‘irritant’ receptors and afferent C-fibres in the lungs by prostaglandins. Nature 1976;264:451–453.
18.
Widdicombe JG: Neurophysiology of the cough reflex. Eur Respir J 1995;8:1193–1202.
19.
Lee SY, Kim MK, Shin C, Shim JJ, Kim HK, Kang KH, Yoo SH, In KH: Substance P-immunoreactive nerves in endobronchial biopsies in cough-variant asthma and classic asthma. Respiration 2003;70:49–53.
20.
Salem H, Aviado DM: Antitussive drugs. Am J Med Sci 1964;247:585–600.
21.
Roberts AM, Kaufman MP, Baker DG, Brown JK, Coleridge HM, Coleridge JC: Reflex tracheal contraction induced by stimulation of bronchial C-fibers in dogs. J Appl Physiol 1981;51:485–493.
22.
Kaufman MP, Coleridge HM, Coleridge JC, Baker DG: Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogs. J Appl Physiol 1980;48:511–517.
23.
Davis B, Roberts AM, Coleridge HM, Coleridge JC: Reflex tracheal gland secretion evoked by stimulation of bronchial C-fibers in dogs. J Appl Physiol 1982;53:985–991.
24.
Fuller RW, Collier JG: Sodium cromoglycate and atropine block the fall in FEV1 but not the cough induced by hypotonic mist. Thorax 1984;39:766–770.
25.
Yanaura S, Hosokawa T, Kitagawa H, Yamatake Y: Influence of tracheal muscular tone on the initiation of the cough reflex. Jpn J Pharmacol 1978;28:447–455.
26.
Eschenbacher WL, Boushey HA, Sheppard D: Alteration in osmolarity of inhaled aerosols cause bronchoconstriction and cough, but absence of a permeant anion causes cough alone. Am Rev Respir Dis 1984;129:211–215.
27.
Godden DJ, Barland C, Lowry R, Higenbottam TW: Chemical specificity of coughing in man. Clin Sci 1986;70:301–306.
28.
Fujimura M, Sakamoto S, Kamio Y, Matsuda T: Effects of methacholine-induced bronchoconstriction and procaterol-induced bronchodilation on cough receptor sensitivity to inhaled capsaicin and tartaric acid. Thorax 1992;47:441–445.
29.
Editorial: Cough and wheeze in asthma: Are they interdependent? Lancet 1988;i:447–448.
30.
Kiljander TO, Salomaa ER, Hietanen EK, Ovaska J, Helenius H, Liippo K: Gastroesophageal reflux and bronchial responsiveness: Correlation and the effect of fundoplication. Respiration 2002;69:434–439.
31.
Riccioni G, D’Orazio N, Di Ilio C, Della Vecchia R, Ballone E, Menna V, Guagnano MT: Bronchial hyperresponsiveness and quality of life in asthmatics. Respiration 2003;70:496–499.
32.
Cockcroft DW: How best to measure airway responsiveness. Am J Respir Crit Care Med 2001;163:1514–1515.
33.
Joos GF, O’Connor B, Anderson SD, Chung F, Cockcroft DW, Dahlén B, DiMaria G, Foresi A, Hargreave FE, Holgate ST, Inman M, Lötvall J, Magnussen H, Polosa R, Postma DS, Riedler J: Indirect airway challenges. Eur Respir J 2003;21:1050–1068.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.